History
2020
05 Announced New Vision “We connect science to life for a better future”
2019
01 Established Global Innovation Center in Boston, USA
04 Established VLBP, a joint venture with VinFast in Vietnam Acquired DuPont's soluble OLED material technologies
07 Became the first Korean chemical company to join the top 10 global chemical companies
11 Constructed Petrochemicals Tech Center in Osan
2018
09 Acquired Uniseal, a U.S. firm specializing in automotive adhesives
03 Acquired the sales approval for Eucept, Korea's first antibody biosimilar
2017
10 Launched Zemiro, treatment for dyslipidemia and Type-2 diabetes & dyslipidemia
07 Established an automotive battery manufacturing subsidiary in Wroclaw, Poland Completed the construction of diagnostic kits factory in Osong Plant
01 Merged with LG Life Sciences in the 70th anniversary of LG Chem's foundation
2016
11 Acquired GSEM
10 Started the construction of vehicle battery plant in Poland Won the international bid to supply the 5-in-1 combination vaccine Eupenta to UNICEF
02 Received WHO’s prequalification approval for Eupenta
01 Acquired Dongbu Farm Hannong
2015
12 Korea’s first diabetes drug Zemiglo approved in India and 7 other foreign countries
10 Completed the construction of battery plant in Nanjing, China Established Huanam(桦南) Tech Center, China
08 Completed the reverse osmosis filter factory for water treatment in Cheongju Complex
06 Developed the world's first hexagon battery
03 Expanded the polarizer plant (24 million m²) in China
2014
11 Expanded the NCC (150,000 tons of ethylene) factory in Yeosu Complex
07 Launched Synovian™, Korea's first single-injection treatment for osteoarthritis
05 Acquired NanoH2O (water treatment filter manufacturer)
01 Completed the expansion of SAP(80,000 tons) factory in Yeosu Complex
2013
10 Established High EVA(140,000 tons) and SSBR(60,000 tons) factories in Deasan
08 Expanded the polymer battery (10 million cells/month) plant in Nanjing, China.
07 Started exporting hyaluronic acid filler Yvoire to China
2012
12 Exported new diabetes drug technologies to Sanofi, France
06 Expanded acrylic acid(160,000 tons) and SAP(80,000 tons) plant Korea's first diabetes treatment approved by KFDA
2011
12 Developed the first meningitis vaccine in Korea
07 Established a petrochemical joint venture in Kazakhstan
04 Expanded the NCC (150,000 tons of ethylene, 75,000 tons of propylene) factory in Daesan Complex and completed the construction of first electric vehicle battery factory in Ochang Plant
03 Launched first Korean hyaluronic filler Yvoire Classic
2010
12 Exported diabetes treatment to Nebel Pharm (Turkey) FACTIVE and Eutropin awarded as Korea's Top 100 Technologies
10 Became the 100% shareholder of LG Polycarbonate through acquisition of remaining 50% shares
07 Started the construction of vehicle battery plant in Michigan, USA
04 Expanded Yeosu NCC(ethylene 100,000 tons, propylene 40,000 tons, etc.)
01 Established HL Green Power Co., LTD., a joint venture with Hyundai Mobis Exported diabetes treatment to Double Crane Pharm (China)
2009
09 Started the construction of TFT-LCD glass plant in LG Paju Industrial Complex Started the construction of vehicle battery plant in Ochang Techno Park
06 Established a SBS manufacturing subsidiary in Tianjin, China
05 Industrial materials business divided (LG Hausys)
04 Domestically launched the pediatric growth hormone Eutropin Plus®
2008
09 Developed and produced the first elastomer, a high value-added resin, in South Korea
08 Acquired Kolon’s SAP business (high absorbent resin) Concluded an MOU on development of electric car batteries with the Ministry of Knowledge and Economy and Hyundai Motor Company
03 Signed an agreement on the development of high-efficiency OLED with UDC in the U.S.
01 Candidate material for hepatitis treatment received Technology Award from Korean New Drug Award
2007
11 Merged with LG Petrochemicals Co., Ltd.
05 Hyruan Plus™ for degenerative arthritis earned European CE marking
04 Expanded Daesan NCC (260,000 tons of ethylene, 130,000 tons of propylene)
01 Sustained release-human growth hormone Declage™ approved by KFDA
2006
10 Expanded the polarizer plant in Ochang Plant (49 million m²)
06 Developed and commercialized Follitrope™, ovulation-inducing drug
01 Merged with LG Daesan Petrochemicals Co., Ltd.
2005
11 Established a polarizer back-end subsidiary in Poland
10 Expanded the polarizer factory in Ochang Plant (26 million m²)
09 Commercialized HYRUAN Plus™ for degenerative arthritis
07 Expanded the acrylate factory in Yeosu Complex (95,000 M/T) Established a sales subsidiary in Europe
06 Established a joint R&D lab with Moscow State University
01 Established LG Daesan Petrochemicals Co., Ltd.
2004
11 Completed the construction of ABS plant in Guangzhou, China
10 Established LG Chem (China) Investment Co., Ltd.
07 Established a sales subsidiary in Taiwan
06 Established an SBL manufacturing subsidiary in Ningbo, China
03 Completed the construction of Ochang Techno Park
02 Quinolone antibiotics FACTIVE® approved as a novel drug in Canada IR52 Chang Young-sil Award of the Year (Presidential Prize) awarded to FACTIVE®
2003
08 Established an IT & electronic materials subsidiary in Nanjing, China
07 Expanded the PVC plant in Tianjin, China (100,000 M/T)
06 Acquired Hyundai Petrochemicals through consortium with Honam Petrochemicals
04 Quinolone antibiotics FACTIVE® approved as a novel drug by USFDA
2002
12 Registered patented technology for production of sustained-release human growth hormones from 22 European countries Received permission to sell FACTIVE® tablets in Korea
10 Expanded the ABS plant in Ningbo, China (150,000 M/T)
08 Completed the construction of EP plant in Guangzhou, China Launched LG Life Sciences (divided from LGCI)
04 Expanded Cheongju Complex, doubling the capacity of rechargeable batteries with investment of KRW 100 billion
02 Expanded the polarizer factory in Cheongju Complex
2001
10 Expanded Tianjin PVC plant in China (90,000 M/T)
04 Divided the company into LGCI, LG Chem, LG Household & Healthcare
03 Established a battery R&D center in the U.S.
2000
11 Acquired Hyundai Petrochemicals’ PVC business
10 Expanded the Ningbo ABS plant in China (90,000 M/T)
07 Developed phosphor for PDP
1999
10 Completed the IT & electronic materials (lithium-ion batteries, optical materials, and MBL negatives) factory Commercialized color filter photoresist for LCD panels
09 Established the rechargeable battery, phosphor, and CCL factories in Cheongju Complex
02 Issued two million global depository receipts (first time for a listed company in South Korea)
1998
07 Completed the Ningbo ABS plant in China
1997
10 Selected as one of Asia’s top companies by Euromoney
04 Expanded the acrylate, EDC/CA, and VCM facotires in Yeosu Complex
1996
11 Acquired India’s Hindustan Polymers Ltd.
1995
02 Renamed to LG Chem
1994
10 Established R&D Campus Daejeon
1993
04 Developed and commercialized the world's first HCFC-resistant synthetic resin
1992
10 Completed the construction of PA factory in Yeosu Complex
1987
05 Completed the construction of acrylate factory in Naju Plant
1985
01 Completed the construction of PS factory in Yeosu Complex
1984
03 Acquired Korea General Chemicals’ Naju Plant
1982
09 Completed the expansion of PVC paste resin factory in Yeosu Complex
1979
10 Opened Lucky Central R&D Center in Daedeok
1978
08 Completed the plastic processing factory in Ulsan Plant
1976
09 Completed the PVC paste resin factory in Yeosu Complex
1974
02 Changed company name to Lucky Ltd.
1969
10 Listed on Korea Stock Exchange
1966
03 Established Korea’s first synthetic detergent factory in Anyang Plant
01 Renamed to Lucky Chemical Industries Co, Ltd
1962
08 Established Lucky Vinyl Co., Ltd.
1959
03 Established Lucky Oil and Fat Co., Ltd
1954
06 Completed Yeonji Plant in Busan (expanded synthetic resin processing facilities)
1951
11 Relocated to Bujeon-dong, Busanjin-gu, Busan (produced Korea’s first injection-molded synthetic resin products)
1947
01 Established Lucky Chemical Co., Ltd. (started manufacturing cosmetics)
2020
05 Announced New Vision “We connect science to life for a better future”
2019
01 Established Global Innovation Center in Boston, USA
04 Established VLBP, a joint venture with VinFast in Vietnam Acquired DuPont's soluble OLED material technologies
07 Became the first Korean chemical company to join the top 10 global chemical companies
11 Constructed Petrochemicals Tech Center in Osan
2018
09 Acquired Uniseal, a U.S. firm specializing in automotive adhesives
07 Became the first Korean chemical company to join the top 10 global chemical companies
03 Acquired the sales approval for Eucept, Korea's first antibody biosimilar
2017
10 Launched Zemiro, treatment for dyslipidemia and Type-2 diabetes & dyslipidemia
07 Established an automotive battery manufacturing subsidiary in Wroclaw, Poland Completed the construction of diagnostic kits factory in Osong Plant
01 Merged with LG Life Sciences in the 70th anniversary of LG Chem's foundation
2016
11 Acquired GSEM
10 Started the construction of vehicle battery plant in Poland Won the international bid to supply the 5-in-1 combination vaccine Eupenta to UNICEF
02 Received WHO’s prequalification approval for Eupenta
01 Received WHO’s prequalification approval for Eupenta
2015
12 Korea’s first diabetes drug Zemiglo approved in India and 7 other foreign countries
10 Completed the construction of battery plant in Nanjing, China Established Huanam(桦南) Tech Center, China
08 < Completed the reverse osmosis filter factory for water treatment in Cheongju Complex
06 < Developed the world's first hexagon battery
03 Expanded the polarizer plant (24 million m²) in China
2014
11 Expanded the NCC (150,000 tons of ethylene) factory in Yeosu Complex
07 Launched Synovian™, Korea's first single-injection treatment for osteoarthritis
05 Acquired NanoH2O (water treatment filter manufacturer)
01 Completed the expansion of SAP(80,000 tons) factory in Yeosu Complex
2013
10 Established High EVA(140,000 tons) and SSBR(60,000 tons) factories in Deasan
08 Expanded the polymer battery (10 million cells/month) plant in Nanjing, China.
07 Started exporting hyaluronic acid filler Yvoire to China
2012
12 Exported new diabetes drug technologies to Sanofi, France
06 Expanded acrylic acid(160,000 tons) and SAP(80,000 tons) plant Korea's first diabetes treatment approved by KFDA
2011
12 Developed the first meningitis vaccine in Korea
07 Established a petrochemical joint venture in Kazakhstan
04 Expanded the NCC (150,000 tons of ethylene, 75,000 tons of propylene) factory in Daesan Complex and completed the construction of first electric vehicle battery factory in Ochang Plant
03 Launched first Korean hyaluronic filler Yvoire Classic
2010
12 Exported diabetes treatment to Nebel Pharm (Turkey) FACTIVE and Eutropin awarded as Korea's Top 100 Technologies
10 Became the 100% shareholder of LG Polycarbonate through acquisition of remaining 50% shares
07 Started the construction of vehicle battery plant in Michigan, USA
04 Expanded Yeosu NCC(ethylene 100,000 tons, propylene 40,000 tons, etc.)
01 Established HL Green Power Co., LTD., a joint venture with Hyundai Mobis Exported diabetes treatment to Double Crane Pharm (China)
2009
09 Started the construction of TFT-LCD glass plant in LG Paju Industrial Complex Started the construction of vehicle battery plant in Ochang Techno Park
06 Established a SBS manufacturing subsidiary in Tianjin, China
05 Industrial materials business divided (LG Hausys)
04 Domestically launched the pediatric growth hormone Eutropin Plus®
2008
09 Developed and produced the first elastomer, a high value-added resin, in South Korea
08 Acquired Kolon’s SAP business (high absorbent resin) Concluded an MOU on development of electric car batteries with the Ministry of Knowledge and Economy and Hyundai Motor Company
03 Signed an agreement on the development of high-efficiency OLED with UDC in the U.S.
01 Candidate material for hepatitis treatment received Technology Award from Korean New Drug Award
2007
11 Merged with LG Petrochemicals Co., Ltd.
05 Hyruan Plus™ for degenerative arthritis earned European CE marking
04 Expanded Daesan NCC (260,000 tons of ethylene, 130,000 tons of propylene)
01 Sustained release-human growth hormone Declage™ approved by KFDA
2006
10 Expanded the polarizer plant in Ochang Plant (49 million m²)
06 Developed and commercialized Follitrope™, ovulation-inducing drug
01 Merged with LG Daesan Petrochemicals Co., Ltd.
2005
11 Established a polarizer back-end subsidiary in Poland
10 Expanded the polarizer factory in Ochang Plant (26 million m²)
09 Commercialized HYRUAN Plus™ for degenerative arthritis
07 Expanded the acrylate factory in Yeosu Complex (95,000 M/T) Established a sales subsidiary in Europe
06 Established a joint R&D lab with Moscow State University
01 Established LG Daesan Petrochemicals Co., Ltd.
2004
11 Completed the construction of ABS plant in Guangzhou, China
10 Established LG Chem (China) Investment Co., Ltd.
07 Established a sales subsidiary in Taiwan
06 Established an SBL manufacturing subsidiary in Ningbo, China
03 Completed the construction of Ochang Techno Park
02 Quinolone antibiotics FACTIVE® approved as a novel drug in Canada IR52 Chang Young-sil Award of the Year (Presidential Prize) awarded to FACTIVE®
2003
08 Established an IT & electronic materials subsidiary in Nanjing, China
07 Expanded the PVC plant in Tianjin, China (100,000 M/T)
06 Acquired Hyundai Petrochemicals through consortium with Honam Petrochemicals
04 Quinolone antibiotics FACTIVE® approved as a novel drug by USFDA
2002
12 Registered patented technology for production of sustained-release human growth hormones from 22 European countries Received permission to sell FACTIVE® tablets in Korea
10 Expanded the ABS plant in Ningbo, China (150,000 M/T)
08 Completed the construction of EP plant in Guangzhou, China Launched LG Life Sciences (divided from LGCI)
04 Expanded Cheongju Complex, doubling the capacity of rechargeable batteries with investment of KRW 100 billion
02 Expanded the polarizer factory in Cheongju Complex
2001
10 Expanded Tianjin PVC plant in China (90,000 M/T)
04 Divided the company into LGCI, LG Chem, LG Household & Healthcare
03 Established a battery R&D center in the U.S.
2000
11 Acquired Hyundai Petrochemicals’ PVC business
10 Expanded the Ningbo ABS plant in China (90,000 M/T)
07 Developed phosphor for PDP
1999
10 Completed the IT & electronic materials (lithium-ion batteries, optical materials, and MBL negatives) factory Commercialized color filter photoresist for LCD panels
09 Established the rechargeable battery, phosphor, and CCL factories in Cheongju Complex
02 Issued two million global depository receipts (first time for a listed company in South Korea)
1998
07 Completed the Ningbo ABS plant in China
1997
10 Selected as one of Asia’s top companies by Euromoney
04 Expanded the acrylate, EDC/CA, and VCM facotires in Yeosu Complex
1996
11 Acquired India’s Hindustan Polymers Ltd.
1995
02 Renamed to LG Chem
1994
10 Established R&D Campus Daejeon
1993
04 Developed and commercialized the world's first HCFC-resistant synthetic resin
1992
10 Completed the construction of PA factory in Yeosu Complex
1987
05 Completed the construction of acrylate factory in Naju Plant
1985
01 Completed the construction of PS factory in Yeosu Complex
1984
03 Acquired Korea General Chemicals’ Naju Plant
1982
09 Completed the expansion of PVC paste resin factory in Yeosu Complex
1979
10 Opened Lucky Central R&D Center in Daedeok
1978
08 Completed the plastic processing factory in Ulsan Plant
1976
09 Completed the PVC paste resin factory in Yeosu Complex
1974
02 Changed company name to Lucky Ltd.
1969
10 Listed on Korea Stock Exchange
1966
03 Established Korea’s first synthetic detergent factory in Anyang Plant
01 Renamed to Lucky Chemical Industries Co, Ltd
1962
08 Established Lucky Vinyl Co., Ltd.
1959
03 Established Lucky Oil and Fat Co., Ltd
1954
06 Completed Yeonji Plant in Busan (expanded synthetic resin processing facilities)
1951
11 Relocated to Bujeon-dong, Busanjin-gu, Busan (produced Korea’s first injection-molded synthetic resin products)
1947
01 Established Lucky Chemical Co., Ltd. (started manufacturing cosmetics)